基于COPD蛋白质技术的预后生物标志物:最近的一项审查
Hanyu Fang1, Ying Liu2, Qiwen Yang1
1Beijing University of Chinese Medicine, Beijing, 100029, People's Republic of China.
概括
本综述探讨了用于预测慢性阻塞性肺病 (COPD) 预后的蛋白质组生物标志物. 它强调了omics技术.
科学领域:
- 肺部医学和奥米克斯技术
背景情况:
- 慢性阻塞性肺病 (COPD) 是一种复杂的呼吸系统疾病,具有空气流量限制.
- 慢性肺炎的异质性和现象复杂性挑战了传统的诊断和管理方法.
- 奥米克技术 (蛋白质组学,代谢组学,转录组学) 为COPD研究提供了新的途径.
研究的目的:
- 通过蛋白质组学研究确定了COPD的预后生物标志物的审查和总结.
- 评估这些蛋白质生物标志物与COPD预后之间的关联.
- 讨论COPD预后生物标志物研究的未来前景和挑战.
主要方法:
- 文献综述,重点关注与COPD预后相关的最近蛋白质学研究.
- 从蛋白质组数据中分析和合成已识别的预后生物标志物.
- 评估生物标志物与COPD结果的临床相关性和关联.
主要成果:
- 蛋白质组学研究已经确定了与COPD预后相关的几种潜在生物标志物.
- 这些生物标志物为COPD的潜在机制和异质性提供了见解.
- 该审查巩固了关于COPD蛋白质性预后标志物的当前知识.
结论:
- 蛋白质组生物标志物显示出改善临床COPD管理中的预后评估的前景.
- 需要进一步的研究来验证这些生物标志物并应对现有的挑战.
- 在推进我们对COPD的理解和治疗方面,omics驱动的方法至关重要.
更多相关视频
相关概念视频
Proteomics
A proteome is the entire set of proteins that a cell type produces. We can study proteomes using the knowledge of genomes because genes code for mRNAs, and the mRNAs encode proteins. Although mRNA analysis is a step in the right direction, not all mRNAs are translated into proteins.
Proteomics is the study of proteomes' function. It involves the large-scale systematic study of the proteome to denote the protein complement expressed by a genome. Scientist Mark Wilkins coined the term proteomics...
Proteomics is the study of proteomes' function. It involves the large-scale systematic study of the proteome to denote the protein complement expressed by a genome. Scientist Mark Wilkins coined the term proteomics...
COPD: Pathogenesis and Clinical Features
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
Chronic Obstructive Pulmonary Disease
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
Medical History
Chronic Obstructive Pulmonary Disease II: Emphysema
Emphysema, a major phenotype of chronic obstructive pulmonary disease (COPD), is characterized by irreversible destruction of alveolar walls and permanent enlargement of distal airspaces. Unlike chronic bronchitis, which primarily affects the airways, emphysema predominantly involves the lung parenchyma, where structural damage leads to airflow limitation.PathophysiologyIt most commonly results from prolonged exposure to cigarette smoke and other toxic gases, particularly cigarette smoke.


